R

Resonance Specialties Ltd
BSE:524218

Watchlist Manager
Resonance Specialties Ltd
BSE:524218
Watchlist
Price: 99.91 INR 1.15%
Market Cap: ₹1.2B

P/E

13
Current
15%
Cheaper
vs 3-y average of 15.3

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
13
=
Market Cap
₹1.2B
/
Net Income
₹88.6m

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
13
=
Market Cap
₹1.2B
/
Net Income
₹88.6m

Valuation Scenarios

Resonance Specialties Ltd is trading below its 3-year average

If P/E returns to its 3-Year Average (15.3), the stock would be worth ₹117.26 (17% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-33%
Maximum Upside
+120%
Average Upside
52%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple 13 ₹99.91
0%
3-Year Average 15.3 ₹117.26
+17%
5-Year Average 8.7 ₹67.13
-33%
Industry Average 26.4 ₹202.93
+103%
Country Average 28.7 ₹220.25
+120%

Forward P/E
Today’s price vs future net income

Not enough data available to calculate forward P/E

Market Distribution

Lower than 84% of companies in India
Percentile
16th
Based on 3 123 companies
16th percentile
13
Low
0 — 18.9
Typical Range
18.9 — 44.4
High
44.4 —
Distribution Statistics
India
Min 0
30th Percentile 18.9
Median 28.7
70th Percentile 44.4
Max 877 228.1

Resonance Specialties Ltd
Glance View

Market Cap
1.2B INR
Industry
Chemicals

Resonance Specialties Ltd. engages in the manufacturing and sale of chemicals. The company is headquartered in Mumbai, Maharashtra and currently employs 53 full-time employees. The firm is a manufacturer with backward integration, and it manufactures its own picolines and pyanopyridine. The firm operates through Chemical Manufacturing segment. The main activity of the Company is manufacturing of pyridine, picoline, cynopyridine and derivatives of the same. Its bulks drugs and nutritional products are toll converted. The firm is involved in multi products manufacturing and frictional distillation in batches and its overall average product cycle is approximately 2-4 months from the procurement till the disposal. The company is also focused on the production of value-added drug intermediates and active pharmaceutical ingredients (APIs). Its products offering include zinc picolinate, chromium picolinate, chromium polynicotinate, niacin and niacinamide. The firm also manufactures anti-tuberculosis products, such as Isoniazid.

RESONANCE Intrinsic Value
147.4 INR
Undervaluation 32%
Intrinsic Value
Price ₹99.91
R
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett